Novartis, Bayer and patent drafting: what’s on this week

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Novartis, Bayer and patent drafting: what’s on this week

Managing IP lists the IP events and lawsuits taking place this week



Tuesday August 21, 2012


The IP Office of the Philippines will be holding a course, Patent Drafting II, for examination passers only, location TBC

Hearing before India’s Intellectual Property Appellate Board in Natco v Bayer, concerning the compulsory license granted to Natco to manufacture generic versions of Bayer’s sorafenib.

Wednesday August 22


India’s Supreme Court is due to hear final arguments between Switzerland’s Novartis against India's patent office over its refusal to grant a patent over cancer drug Glivec.

The USPTO is seeking volunteers to test the new electronic filing system for administrative trials linked to post grant review, inter partes review and the transitional programme for covered business methods.

Friday August 24, 2012


The IP Office of the Philippines will be hosting a meeting with the Japan-Asia Young Scientist & Engineer Study (JAYSES) at its offices in Taguig City.

Last day of Apple v Samsung trial in California.



more from across site and SHARED ros bottom lb

More from across our site

The insensitive reaction to a UK politician crying on TV proves we have a long way to go before we can say we are tackling workplace wellbeing
Adrian Percer says he was impressed by the firm’s work on billion-dollar cases as well as its culture
In our latest interview with women IP leaders, Catherine Bonner at Murgitroyd discusses technology, training, and teaching
Developments included an update in the VAR dispute between Ballinno and UEFA, the latest CMS updates, and a swathe of market moves
The LMG Life Sciences Americas Awards is thrilled to present the 2025 shortlist
A new order has brought the total security awarded to a Canadian tech company to $45 million, the highest-ever by an Indian court in an IP case
Andrew Blattman reflects on how IP practices have changed and shares his hopes for increased AI use and better performance on the stock market
The firm said major IP developments included advising on a ‘landmark’ deal involving green hydrogen production, as well as two major acquisitions
The appointments follow other recent moves in the European market as firms look to bolster their UPC offerings
Deborah Kirk discusses why IP and technology have become central pillars in transactions and explains why clients need practically minded lawyers
Gift this article